This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Apogee Therapeutics (APGE) and Align Tech (ALGN)

Tipranks - Tipranks - Fri May 29, 10:04AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Assembly Biosciences (ASMB), Apogee Therapeutics (APGE) and Align Tech (ALGN) with bullish sentiments.

Memorial Day Sale – Claim 70% Off TipRanks

Assembly Biosciences (ASMB)

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Assembly Biosciences today and set a price target of $50.00. The company’s shares closed last Thursday at $27.52.

According to TipRanks.com, Trucchio is a 5-star analyst with an average return of 25.1% and a 52.3% success rate. Trucchio covers the Healthcare sector, focusing on stocks such as Harmony Biosciences Holdings, Arrowhead Pharmaceuticals, and Alto Neuroscience, Inc. ;'>

Currently, the analyst consensus on Assembly Biosciences is a Strong Buy with an average price target of $44.33, representing a 62.4% upside. In a report issued on May 22, TipRanks – xAI also upgraded the stock to Buy with a $29.00 price target.

See today’s best-performing stocks on TipRanks >>

Apogee Therapeutics (APGE)

The company’s shares closed last Thursday at $78.50.

According to TipRanks.com, Meacham is a 5-star analyst with an average return of 9.8% and a 56.1% success rate. Meacham covers the Healthcare sector, focusing on stocks such as Amylyx Pharmaceuticals Inc, Protagonist Therapeutics, and Kiniksa Pharmaceuticals. ;'>

Apogee Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $118.00, representing a 51.5% upside. In a report released yesterday, TipRanks – DeepSeek also upgraded the stock to Buy with a $93.00 price target.

Align Tech (ALGN)

The company’s shares closed last Thursday at $170.00, close to its 52-week low of $157.57.

According to TipRanks.com, Grosslight is a 3-star analyst with an average return of 1.3% and a 43.9% success rate. Grosslight covers the Healthcare sector, focusing on stocks such as Elanco Animal Health, Phibro Animal Health, and Privia Health Group. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Align Tech with a $208.00 average price target, a 27.7% upside from current levels. In a report issued on May 16, TipRanks – Google also upgraded the stock to Buy with a $180.00 price target.

Read More on ASMB:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).